Found 4 articles for: "Cancers"
Beyond the Label: Real-World Side Effects Experienced With FDA-Approved Drugs for Non-Melanoma Skin Cancers
May 2024 | Volume 23 | Issue 5 | Original Article | 301 | Copyright © May 2024
With immunotherapy historically focused on cutaneous melanoma, there has been a new wave of systemic medications available for treating non-melanoma skin cancers including basal cell carcinoma (B...
Read MoreThe Representation of Skin Tones in Google Images of Skin Cancers
May 2024 | Volume 23 | Issue 5 | Editorials | e132 | Copyright © May 2024
Skin self-examinations play a vital role in skin cancer detection and are often aided by online resources. Available reference photos must display the full spectrum of skin tones so patients may ...
Read MoreConsistency in Distribution of Facial Skin Cancers Treated With Mohs Micrographic Surgery
May 2022 | Volume 21 | Issue 5 | Original Article | 506 | Copyright © May 2022
Mohs micrographic surgery (MMS) has become the standard of treatment for skin malignancies of the head and neck. However, there is a paucity of literature describing facial distributions of MMS. Anato...
Read MoreA Non-Surgical and Cost-Effective Treatment Approach Employing Topical Imiquimod, 5-Fluorouracil, and Tretinoin for Primary Non-Melanoma Skin Cancers
March 2021 | Volume 20 | Issue 3 | Original Article | 260 | Copyright © March 2021
Background: Minimally invasive alternative approaches to treat non-melanoma skin cancers remain limited and unproven.
Objective: We aim to assess the efficacy o...
Read More
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.